Dr. Gartner joined the Clinical Research group at Zymeworks in November 2019 and has been serving as Vice President of Late-Stage Development since February 2023. Dr. Gartner is an oncologist with over 20 years of experience in clinical research, more than 10 years of which has been spent in the biotechnology industry. Prior to joining Zymeworks, Dr. Gartner was at Seattle Genetics where she led the initial clinical development for PADCEV®, including its first FDA submission for accelerated approval. Dr. Gartner was a practicing breast cancer specialist and clinical researcher at The Barbara Ann Karmanos Cancer Institute affiliated with Wayne State University before moving into the biotechnology industry. Dr. Gartner received a M.D. degree from Washington University in St. Louis and subsequently trained in Internal Medicine at the University of Iowa, followed by a Hematology/Oncology subspecialty fellowship at the University of Michigan.